A detailed history of Smith, Salley & Associates transactions in Stryker Corp stock. As of the latest transaction made, Smith, Salley & Associates holds 5,485 shares of SYK stock, worth $2.08 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,485
Previous 5,168 6.13%
Holding current value
$2.08 Million
Previous $2.04 Million 0.83%
% of portfolio
0.11%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$368.57 - $403.53 $116,836 - $127,919
317 Added 6.13%
5,485 $2.03 Million
Q2 2025

Jul 17, 2025

BUY
$337.37 - $395.63 $1.74 Million - $2.04 Million
5,168 New
5,168 $2.04 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $144B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.